XML 95 R87.htm IDEA: XBRL DOCUMENT v3.24.3
Segment Reporting - Schedule of Business Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Segment Reporting Information [Line Items]        
Total revenue $ 44,969 $ 25,367 $ 127,714 $ 78,152
Income (loss) from operations (31,718) (21,172) (142,419) (55,214)
Restructuring and related charges (2,341) (1,998) (12,374) (5,415)
Transaction and integration expenses (5,079) (1,666) (25,024) (1,666)
Depreciation & amortization 3,858 3,986 12,908 11,274
Corporate expenses        
Segment Reporting Information [Line Items]        
Income (loss) from operations (16,013) (10,703) (59,217) (31,877)
Restructuring and related charges (2,341) (1,715) (12,374) (4,095)
Proteomics        
Segment Reporting Information [Line Items]        
Total revenue 34,565 14,008 98,954 47,296
Depreciation & amortization 1,940 3,420 7,193 9,932
Proteomics | Operating segments        
Segment Reporting Information [Line Items]        
Income (loss) from operations (10,210) (7,106) (48,485) (16,297)
Restructuring and related charges 0 (213) 0 (691)
Genomics        
Segment Reporting Information [Line Items]        
Total revenue 10,404 11,359 28,760 30,856
Income (loss) from operations 1,925 301 2,681 41
Depreciation & amortization 378 373 1,125 703
Genomics | Operating segments        
Segment Reporting Information [Line Items]        
Restructuring and related charges 0 (70) 0 (629)
Corporate        
Segment Reporting Information [Line Items]        
Depreciation & amortization $ 1,540 $ 193 $ 4,590 $ 639